Search

everythinglearnresearchcommunity

for

Search:↓

Ingrown hairs are a common feature in scarring alopecias due to follicular damage.

D-OCT shows increased blood vessel growth in response to tissue damage in Frontal Fibrosing Alopecia and is useful for diagnosis and monitoring.

Early and aggressive treatment of scarring alopecia is important to prevent further hair follicle damage.

Injecting a person's own fat into their scalp may help regrow hair and improve hair thickness in different types of hair loss.

The study found that a key immune pathway protecting hair follicles is reduced in a mouse model of scarring hair loss.

Fibrosing alopecia in a pattern distribution is a new type of scarring hair loss that resembles common baldness and an autoimmune skin disease.

Hair loss without scarring is more common than permanent hair loss with scarring, and is often due to genetic factors.

Frontal fibrosing alopecia causes hairline recession and eyebrow loss in postmenopausal women.

The conclusion is that accurate diagnosis of different types of hair loss requires good teamwork between skin doctors and lab experts.

The conclusion is that FFA and LPP have similar scalp biopsy features, making them hard to distinguish histologically, and FFA may be a specific kind of scarring hair loss.

The document concludes that proper diagnosis and a combination of medical, hair-care, and surgical treatments are important for managing alopecia in black women.

Oral dutasteride can potentially treat frontal fibrosing alopecia in postmenopausal women, with some patients showing disease arrest and hair regrowth.

Tight hairstyles and chemical relaxers can cause hair loss known as traction alopecia.

A Gsdma3 mutation causes hair loss due to stem cell damage from skin inflammation.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

A scale was made to measure hair loss severity in African American women.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

The document concluded that more research is needed to find the best treatment for Frontal fibrosing alopecia.

Using CD123 to detect certain immune cells helps diagnose a type of hair loss condition.

Nonscarring alopecia has higher hair density than scarring alopecia, and hair density can help diagnose the type of alopecia.

Platelet-rich plasma (PRP) may help treat hair loss in patients with frontal fibrosing alopecia who don't respond to other treatments.

Some people's hair loss is caused by multiple factors, with the most common being a mix of AGA and CCCA.

Finasteride's effectiveness for frontal fibrosing alopecia is uncertain.

The document concludes that it's important to recognize and treat hair loss in women of color, considering their unique hair characteristics and psychological impact.

Certain mutations in the PADI3 gene may increase the risk of developing a type of scarring hair loss common in women of African descent.

Three characteristics of plasmacytoid dendritic cells help tell apart lupus-related hair loss from LPP.

Alopecia causes hair loss and should be treated early, especially scarring types where hair cannot regrow.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

Minoxidil may help with hair regrowth and disease stabilization in scarring alopecia, but side effects vary, needing more research for consistent safety and effectiveness.

Biopsies matched initial diagnoses in 76.6% of black women with alopecia and led to treatment changes in 44% of cases.